Concepedia

Amy Lawless

AL

Statistics

Publications

6

Citations

120

H-Index

6

Active since

2000

Affiliations

Duke Medical Center(Current)

Duke University Hospital

The University of Texas at Austin

Duke University

Amy Lawless is an author at Duke Medical Center specializing in medicine, pharmacology, and neuro-oncology.

Top concepts

Publications per year

2000–2010

6

Publications

6

Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice

Stephen T. Keir, Frederick H. Hausheer, Amy Lawless et al. · Cancer Chemotherapy and Pharmacology · 2001 · 29 citations

, , +8

Comparing an Early Corticosteroid/Late Calcineurin-Free Immunosuppression Protocol to a Sirolimus-, Cyclosporine A-, and Prednisone-Based Regimen for Pancreas-Kidney Transplantation

Richard J. Knight, Hemangshu Podder, Ronald H. Kerman et al. · Transplantation · 2010 · 23 citations

O 6 -Benzylguanine-mediated enhancement of nitrosourea activity in Mer − central nervous system tumor xenografts - implications for clinical trials

Stephen T. Keir, M. Eileen Dolan, Anthony E. Pegg et al. · Cancer Chemotherapy and Pharmacology · 2000 · 20 citations

, , +7

Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic mice

Henry S. Friedman, Stephen T. Keir, Peter J. Houghton et al. · Cancer Chemotherapy and Pharmacology · 2001 · 17 citations

, , +9

Selective corticosteroid and calcineurin‐inhibitor withdrawal after pancreas–kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy

Rose Knight, Ronald H. Kerman, Eva McKissick et al. · Clinical Transplantation · 2008 · 16 citations

1–5 of 6